CA2219437A1 - Peptides utilises comme analgesiques - Google Patents

Peptides utilises comme analgesiques Download PDF

Info

Publication number
CA2219437A1
CA2219437A1 CA 2219437 CA2219437A CA2219437A1 CA 2219437 A1 CA2219437 A1 CA 2219437A1 CA 2219437 CA2219437 CA 2219437 CA 2219437 A CA2219437 A CA 2219437A CA 2219437 A1 CA2219437 A1 CA 2219437A1
Authority
CA
Canada
Prior art keywords
arg
gly
peptides
gln
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2219437
Other languages
English (en)
Inventor
Simon Lemaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
University of Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Ottawa filed Critical University of Ottawa
Priority to CA 2219437 priority Critical patent/CA2219437A1/fr
Priority to CA002224066A priority patent/CA2224066A1/fr
Priority to CA002306754A priority patent/CA2306754A1/fr
Priority to PCT/CA1998/001002 priority patent/WO1999021877A1/fr
Priority to AT98951127T priority patent/ATE302210T1/de
Priority to AU97311/98A priority patent/AU9731198A/en
Priority to US09/530,123 priority patent/US6566327B1/en
Priority to DE69831257T priority patent/DE69831257D1/de
Priority to EP98951127A priority patent/EP1025119B1/fr
Publication of CA2219437A1 publication Critical patent/CA2219437A1/fr
Priority to US10/437,435 priority patent/US6855692B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2219437 1997-10-24 1997-10-24 Peptides utilises comme analgesiques Abandoned CA2219437A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CA 2219437 CA2219437A1 (fr) 1997-10-24 1997-10-24 Peptides utilises comme analgesiques
CA002224066A CA2224066A1 (fr) 1997-10-24 1998-02-24 Peptides utilises comme analgesiques
AU97311/98A AU9731198A (en) 1997-10-24 1998-10-26 Histogranin peptide and their analgesic use
PCT/CA1998/001002 WO1999021877A1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides
AT98951127T ATE302210T1 (de) 1997-10-24 1998-10-26 Histogranin peptide und deren analgetische verwendung
CA002306754A CA2306754A1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides
US09/530,123 US6566327B1 (en) 1997-10-24 1998-10-26 Histogranin peptides and their analgesic use
DE69831257T DE69831257D1 (de) 1997-10-24 1998-10-26 Histogranin peptide und deren analgetische verwendung
EP98951127A EP1025119B1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides
US10/437,435 US6855692B2 (en) 1997-10-24 2003-05-14 Histogranin peptides and their analgesic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2219437 CA2219437A1 (fr) 1997-10-24 1997-10-24 Peptides utilises comme analgesiques

Publications (1)

Publication Number Publication Date
CA2219437A1 true CA2219437A1 (fr) 1999-04-24

Family

ID=4161693

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2219437 Abandoned CA2219437A1 (fr) 1997-10-24 1997-10-24 Peptides utilises comme analgesiques

Country Status (1)

Country Link
CA (1) CA2219437A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972281B2 (en) 2002-02-07 2005-12-06 University Of Ottawa Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972281B2 (en) 2002-02-07 2005-12-06 University Of Ottawa Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
US7074786B2 (en) 2002-02-07 2006-07-11 University Of Ottawa Histogranin-like peptides, processes for their preparation and uses thereof
US7183279B2 (en) 2002-02-07 2007-02-27 University Of Ottawa Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof

Similar Documents

Publication Publication Date Title
EP0674652B1 (fr) Analogue de dolastatine
BRPI0715407A2 (pt) peptÍdeos e seus derivados funcionalmente equivalentes, composiÇÕes farmacÊuticas e usos dos mesmos
CA2121724A1 (fr) Methodes et compositions pour la prophylaxie et/ou le traitement de l'hypofonction organique
JP3838656B2 (ja) ポリペプチドのボンベシン拮抗物質
CA2224066A1 (fr) Peptides utilises comme analgesiques
CA1271600A (fr) Peptides liberant l'hormone de croissance et methode de traitement chez les mammiferes
AU733103B2 (en) Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
JPS61191698A (ja) 新規な環状ヘキサペプチドｌｈｒｈ拮抗剤
EP0759772B1 (fr) Tri-, tetra-, penta- et polypeptides et leur usage therapeutique en tant qu'agent antidepresseur
CA1291592C (fr) Antagonistes peptidiques de la neurokinine b
EP1021200B1 (fr) Methodes et compositions de traitement de la polyarthrite rhumatoide
CA2219437A1 (fr) Peptides utilises comme analgesiques
AU653544B2 (en) Bombesin antagonists
US5767083A (en) Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
AU718192B2 (en) Peptide derivatives
EP0517464A1 (fr) Peptides de régulation du système immunitaire et du système nerveux
CA2405724C (fr) Analogues de la substance p destines au traitement du cancer
US6093797A (en) Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent
WO1995024424A1 (fr) Peptides cycliques antagonistes de lhrh
CA2306754A1 (fr) Peptides histoganine et utilisation de ces peptides
AU7240694A (en) Peptides exhibiting oxytocin antagonistic activity
Seldon et al. High-volume vivo pharmacological screening of angiotensin II-related peptides synthesized by the multipin method

Legal Events

Date Code Title Description
FZDE Dead